Several fusions have been tested clinically to show that antigenicity has not been a major problem, such as anti-TNFR fusions (42), DAB389IL-2 (43), and VEGFR fusion (VEGF-Trap in patients with solid tumors and non-Hodgkin's lymphomas; ref.